Stimuli-responsive polymer-based nanosystems for cancer theranostics

D Wei, Y Sun, H Zhu, Q Fu - ACS nano, 2023 - ACS Publications
Stimuli-responsive polymers can respond to internal stimuli, such as reactive oxygen
species (ROS), glutathione (GSH), and pH, biological stimuli, such as enzymes, and external …

Pluronic® triblock copolymer-based nanoformulations for cancer therapy: A 10-year overview

KC de Castro, JC Coco, ÉM Dos Santos… - Journal of Controlled …, 2023 - Elsevier
This paper provides a review of the literature on the use of Pluronic® triblock copolymers for
drug encapsulation over the last 10 years. A special focus is given to the progress of drug …

Exploring the application of micellar drug delivery systems in cancer nanomedicine

Q Wang, K Atluri, AK Tiwari, RJ Babu - Pharmaceuticals, 2023 - mdpi.com
Various formulations of polymeric micelles, tiny spherical structures made of polymeric
materials, are currently being investigated in preclinical and clinical settings for their …

Tyrosinase‐Woven Melanin Nets for Melanoma Therapy through Targeted Mitochondrial Tethering and Enhanced Photothermal Treatment

M Tang, T Duan, Y Lu, J Liu, C Gao… - Advanced …, 2024 - Wiley Online Library
Manipulating intracellular biological processes and organelles has emerged as a pivotal
strategy to influence cellular physiological functions. Mitochondria, recognized as the …

Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐and radioresistances

P Kola, PKB Nagesh, PK Roy, K Deepak… - Wiley …, 2023 - Wiley Online Library
The alarming increase in the number of breast cancer patients worldwide and the increasing
death rate indicate that the traditional and current medicines are insufficient to fight against …

Polyhydroxyalkanoates (PHAs) and its copolymer nanocarrier application in cancer treatment: An overview and challenges

V Paul, S Pandhi, DK Mahato, A Agarwal… - International Journal of …, 2024 - Elsevier
In the modern era, nanomedicine has developed novel drug-delivery strategies to improve
chemotherapy. Nanotechnological-based treatment approaches for cancer through targeted …

Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy

Z Liu, X Liu, W Zhang, R Gao, H Wei, CY Yu - Acta Biomaterialia, 2024 - Elsevier
Hypoxia is a common feature of most solid tumors, which promotes the proliferation,
invasion, metastasis, and therapeutic resistance of tumors. Researchers have been …

Targeted Cancer Therapy‐on‐A‐Chip

H Abed, R Radha, S Anjum, V Paul… - Advanced …, 2024 - Wiley Online Library
Targeted cancer therapy (TCT) is gaining increased interest because it reduces the risks of
adverse side effects by specifically treating tumor cells. TCT testing has traditionally been …

Engineering hypoxia-responsive 6-aminonicotinamide prodrugs for on-demand NADPH depletion and redox manipulation

M Li, Y Dong, Z Wang, Y Zhao, Y Dai… - Journal of Materials …, 2024 - pubs.rsc.org
Glucose-6-phosphate dehydrogenase (G6PD) is a promising target in cancer therapy.
However, poor cellular uptake and off-target toxicity have impeded the clinical translation of …

Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders

J Wu, L Ma, D Sun, X Zhang, J Cui, Y Du, Y Guo… - Nano Research, 2023 - Springer
Despite noteworthy technological progress and promising preclinical trials, brain disorders
are still the leading causes of death globally. Extracellular vesicles (EVs), nano-/micro-sized …